Arrowhead Pharmaceuticals ARWR Balance Sheet (2010-2026)

NASDAQ ARWR
$86.36 -0.13 (-0.15%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Arrowhead Pharmaceuticals Quarterly Balance Sheet

Periods 65 quarters
Latest Jun 2026

Arrowhead Pharmaceuticals reported total assets of $2112.01M and total liabilities of $1645.97M for the quarter ended Jun 2026, up 53.0% year over year. This balance sheet covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
184.43M91.60M86.41M139.44M108.00M202.25M134.96M105.33M110.89M58.22M127.70M69.40M102.69M53.89M185.71M129.79M226.55M201.64M188.52M54.80M
Short-term InvestmentsInvestments (Current)
126.73M126.01M192.91M277.10M268.39M299.60M346.05M346.40M292.74M162.10M395.41M367.30M578.28M499.05M911.70M770.58M692.82M715.00M1,595.60M1,547.20M
Cash & Current Investments
311.16M217.61M279.32M416.54M376.40M501.85M481.00M451.73M403.63M220.31M523.11M436.70M680.96M552.93M1,097.41M900.37M919.37M916.64M1,784.12M1,602.00M
Receivables - NetNet Receivables
10.26M0.15M1.32M0.24M1.41M39.57M70.00M1.54M2.50M2.37M9.70M6.82M218.87M15.69M15.26M
Receivables - OtherOther Receivables
10.00M0.10M1.30M4.80M25.00M1.50M9.83M10.23M
Receivables
20.25M0.25M2.62M0.24M6.21M64.57M70.00M3.04M2.50M2.37M9.70M6.82M228.70M15.69M25.49M
Prepaid Assets
4.36M5.20M7.80M8.89M20.20M25.19M14.44M10.05M8.81M10.52M11.02M9.21M9.54M9.37M23.77M23.69M13.52M22.86M21.72M35.52M
Current Assets
384.60M338.28M417.63M432.39M405.30M575.00M574.81M470.17M416.47M237.90M541.65M450.06M695.47M570.54M1,135.22M946.92M950.64M1,174.39M1,839.75M1,671.41M
Non-Current Assets
Construction in Progress
0.34M2.15M6.41M22.34M56.37M90.22M127.22M118.28M166.66M
Land & Improvements
3.00M3.00M
Property, Plant & Equipment (Net)PP&E (Net)
48.67M52.30M54.89M71.90M110.30M147.31M185.23M231.37M290.26M333.41M359.25M375.91M386.03M387.07M384.80M381.05M382.51M378.58M374.82M373.30M
Long-Term Investments
245.59M217.60M201.60M165.92M105.87M115.80M78.83M42.80M
Intangibles
13.66M13.24M12.81M12.39M11.96M11.54M11.11M10.69M10.26M9.84M9.41M8.99M8.56M8.14M7.71M7.29M6.86M6.44M6.01M5.59M
Goodwill & Intangibles
13.66M13.24M12.81M12.39M11.96M11.54M11.11M10.69M10.26M9.84M9.41M8.99M8.56M8.14M7.71M7.29M6.86M6.44M6.01M5.59M
Long-Term Deferred Tax
Other Non-Current Assets
0.27M0.27M0.28M0.28M0.22M0.21M0.21M0.21M3.26M0.23M0.21M4.46M4.48M3.08M1.31M1.35M1.39M1.41M4.89M6.05M
Non-Current Assets
325.55M300.26M285.94M319.39M286.64M316.49M316.50M325.69M349.08M388.39M413.50M433.70M444.33M443.16M438.28M433.69M434.66M429.79M428.51M440.60M
Assets
710.15M638.54M703.58M751.78M691.94M891.49M891.31M795.86M765.55M626.29M955.15M883.76M1,139.80M1,013.69M1,573.50M1,380.61M1,385.30M1,604.18M2,268.26M2,112.01M
Liabilities
Current Liabilities
Accounts Payables
9.46M4.07M10.60M5.89M2.87M0.80M9.56M7.87M35.87M4.46M8.52M26.55M11.39M14.46M9.98M33.05M17.67M32.94M30.75M27.78M
Notes Payables
Payables
9.46M4.07M10.60M5.89M2.87M0.80M9.56M7.87M35.87M4.46M8.52M26.55M11.39M14.46M9.98M33.05M17.67M32.94M30.75M27.78M
Accumulated Expenses
14.00M18.52M23.71M32.50M46.86M48.17M39.55M38.19M39.76M46.60M37.05M47.90M63.02M59.40M78.45M64.82M90.42M130.08M76.58M86.17M
Other Accumulated Expenses
0.43M0.46M0.57M0.42M0.43M0.44M0.45M7.38M10.81M10.68M11.21M6.02M
Short term Debt
1.62M65.00M40.00M40.00M40.00M40.00M40.00M
Current Leases
2.25M2.83M2.91M2.88M2.78M2.66M2.71M2.82M10.56M3.42M5.29M6.05M6.34M6.56M6.78M7.01M7.29M7.53M7.77M5.32M
Current Deferred Revenue
111.06M108.65M97.87M84.29M130.05M66.28M30.91M16.91M0.87M43.27M22.98M2.40M111.93M108.54M94.60M
Total Current Liabilities
146.54M137.03M138.86M128.21M138.85M122.01M87.15M70.23M105.46M63.72M65.17M96.71M103.17M93.76M220.54M194.53M195.49M347.43M295.22M283.35M
Non-Current Liabilities
Capital Leases
Non-Current Debt
393.18M407.79M208.93M200.33M214.88M163.11M159.64M181.40M
Convertible Debt
681.94M682.71M
Non-Current Deffered Revenue
131.50M106.46M89.75M71.16M55.95M40.79M1.07M53.83M48.62M31.74M
Minority Interest
20.25M19.82M19.33M18.33M17.16M15.82M13.31M11.61M8.43M5.62M3.49M0.90M-2.51M37.36M-5.72M-15.06M0.51M
Operating Leases
23.30M22.49M22.70M81.11M78.80M82.13M82.78M82.73M104.61M118.58M118.92M118.09M111.03M115.86M114.31M112.70M104.11M109.66M107.88M119.62M
Other Non-Current Liabilities
252.85M257.91M263.06M268.33M273.69M280.94M336.03M341.36M346.78M352.28M360.25M367.40M375.00M383.83M392.51M
Total Non-Current Liabilities
154.79M128.95M112.45M149.39M134.75M373.11M339.05M343.64M372.93M388.85M394.57M448.07M845.57M863.86M668.73M666.28M686.39M694.06M1,374.13M1,362.63M
Total Liabilities
301.33M265.98M251.31M277.61M273.60M495.12M426.20M413.87M478.39M452.57M459.75M544.78M948.74M957.62M889.27M860.81M881.88M1,041.48M1,669.35M1,645.97M
Shareholder's Equity
Total Debt
393.18M409.41M273.93M240.33M254.88M203.11M199.64M221.40M
Common Equity
408.82M372.56M452.27M474.18M418.34M396.37M465.11M381.99M287.16M173.71M495.40M338.97M191.06M56.08M684.23M519.81M503.42M562.70M598.92M466.04M
Liabilities and Shareholders Equity
710.15M638.54M703.58M751.78M691.94M891.49M891.31M795.86M765.55M626.29M955.15M883.76M1,139.80M1,013.69M1,573.50M1,380.61M1,385.30M1,604.18M2,268.26M2,112.01M
Treasury Shares
Retained Earnings
-644.69M-707.56M-663.20M-735.24M-820.75M-862.08M-813.40M-916.35M-1026.03M-1158.89M-1284.19M-1454.99M-1625.52M-1798.61M-1428.16M-1603.40M-1627.15M-1596.34M-1729.08M-1923.36M
Preferred Shares